Cureous Labs Secures Rs 1.66 Cr Seed Funding for Medtech Innovation

Cureous Labs has raised Rs 1.66 crore in Seed funding led by Inflection Point Ventures, with participation from Anthill Ventures.

Founded by Asish Mohandas in 2019, India, Cureous Labs is building automated patient repositioning systems to prevent pressure injuries and enhance caregiver efficiency.

Their flagship product, Eturnal™, is an automated patient turning solution that helps prevent pressure injuries while reducing caregiver dependency and effort.

The fresh capital will be used to produce the first batch of its flagship product Eturnal, build inventory, grow the sales and business development team, launch the first disinfection centre, and complete product safety testing and certifications.

Priced at one-fifth of international alternatives, the device is suited for hospitals, rehabilitation centres, and home care.

The company reports over 30,000 hours of use and more than 14,000 automated patient turns.